Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Cancer Research
|
July 1, 1988
Relation of proliferative activity to survival in patients with advanced germ cell cancer
G W Sledge, J N Eble, B J Roth, et al.
Gynecologic Oncology
|
September 1, 1989
DNA content as a prognostic index in gestational trophoblastic neoplasia
D A Martin, G P Sutton, T M Ulbright, et al.
Oncology (Williston Park, N.Y.)
|
March 17, 2001
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer
K D Miller, J Sisk, R Ansari, et al.
Cancer Research
|
August 25, 1991
Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation
J F Fleck, G W Sledge, S V Benenati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study
J A Sparano, D Neuberg, J H Glick, et al.
Cancer Research
|
April 20, 2001
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors
C J Sweeney, K D Miller, S E Sissons, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment
A Shafqat, L H Einhorn, N Hanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
K D Miller, W Gradishar, L Schuchter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer
M S Gordon, K Margolin, M Talpaz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
May 1, 1983
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity
D R Ciocca, D J Adams, R J Bjercke, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Cancer Research
|
July 1, 1988
Relation of proliferative activity to survival in patients with advanced germ cell cancer
G W Sledge, J N Eble, B J Roth, et al.
Gynecologic Oncology
|
September 1, 1989
DNA content as a prognostic index in gestational trophoblastic neoplasia
D A Martin, G P Sutton, T M Ulbright, et al.
Oncology (Williston Park, N.Y.)
|
March 17, 2001
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer
K D Miller, J Sisk, R Ansari, et al.
Cancer Research
|
August 25, 1991
Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation
J F Fleck, G W Sledge, S V Benenati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study
J A Sparano, D Neuberg, J H Glick, et al.
Cancer Research
|
April 20, 2001
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors
C J Sweeney, K D Miller, S E Sissons, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment
A Shafqat, L H Einhorn, N Hanna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer
K D Miller, W Gradishar, L Schuchter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2001
Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer
M S Gordon, K Margolin, M Talpaz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
May 1, 1983
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity
D R Ciocca, D J Adams, R J Bjercke, et al.
Page
of 12